During the last session, Moleculin Biotech Inc (NASDAQ:MBRX)’s traded shares were 0.27 million, with the beta value of the company hitting 1.60. At the end of the trading day, the stock’s price was $0.87, reflecting an intraday loss of -4.80% or -$0.05. The 52-week high for the MBRX share is $5.47, that puts it down -528.74 from that peak though still a striking 54.02% gain since the share price plummeted to a 52-week low of $0.40. The company’s market capitalization is $12.36M, and the average intraday trading volume over the past 10 days was 0.34 million shares, and the average trade volume was 5.66 million shares over the past three months.

Moleculin Biotech Inc (NASDAQ:MBRX) trade information

Moleculin Biotech Inc (MBRX) registered a -4.80% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -4.80% in intraday trading to $0.87, hitting a weekly high. The stock’s 5-day price performance is 19.67%, and it has moved by -15.87% in 30 days. Based on these gigs, the overall price performance for the year is -79.56%. The short interest in Moleculin Biotech Inc (NASDAQ:MBRX) is 0.57 million shares and it means that shorts have 0.72 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 26.36%. While earnings are projected to return 73.47% in 2025, the next five years will return 37.81% per annum.

MBRX Dividends

Moleculin Biotech Inc is due to release its next quarterly earnings on 2025-Mar-20. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Moleculin Biotech Inc (NASDAQ:MBRX)’s Major holders

Moleculin Biotech Inc insiders own 0.72% of total outstanding shares while institutional holders control 3.32%, with the float percentage being 3.34%.